Picture of Nicox SA logo

ALCOX — Nicox SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Nicox Q1 Net Revenue At 0.6 Million Euros

April 19 (Reuters) - NICOX SA  NCOX.PA :
    * PROVIDES FIRST QUARTER 2021 BUSINESS UPDATE AND FINANCIAL
HIGHLIGHTS
    * Q1 2021 NET REVENUE OF EUR 0.6 MILLION AND CASH OF EUR
42.0
MILLION AT MARCH 31, 2021
    * NCX 470 PHASE 3 TRIALS IN GLAUCOMA ON TRACK FOR TOP-LINE
RESULTS
IN Q2 2022 (MONT BLANC) AND Q4 2022 (DENALI)
    * NCX 4251 MISSISSIPPI PHASE 2B TRIAL IN BLEPHARITIS ON
TRACK FOR
TOP-LINE RESULTS IN Q4 2021
    * U.S. PRESCRIPTIONS FOR VYZULTA IN Q1 2021INCREASED BY
10.6% OVER
Q1 2020, AND FOR ZERVIATE BY 29.1% OVER Q4 2020

Source text for Eikon:  ID:nGNX2NfGXC 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Nicox SA

See all news